Related references
Note: Only part of the references are listed.SciPy 1.0: fundamental algorithms for scientific computing in Python
Pauli Virtanen et al.
NATURE METHODS (2020)
Defining Success in Measurement-Based Care for Depression: A Comparison of Common Metrics
R. Yates Coley et al.
PSYCHIATRIC SERVICES (2020)
Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments
Kyle T. Greenway et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2020)
Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials
Joanna Kryst et al.
PHARMACOLOGICAL REPORTS (2020)
A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression
Paulo R. Shiroma et al.
TRANSLATIONAL PSYCHIATRY (2020)
Array programming with NumPy
Charles R. Harris et al.
NATURE (2020)
The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis
Roger S. McIntyre et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Long-term outcome in outpatients with depression treated with acute and maintenance intravenous ketamine: A retrospective chart review
Hitoshi Sakurai et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Anxiety during ketamine infusions is associated with negative treatment responses in major depressive disorder
Sabine Aust et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
Vanina Popova et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression A Randomized Clinical Trial
Ella J. Daly et al.
JAMA PSYCHIATRY (2019)
Effects of ketamine on circadian rhythm and synaptic homeostasis in patients with treatment-resistant depression: A protocol for mechanistic studies of its rapid and sustained antidepressant actions in humans
Chuanjun Zhuo et al.
BRAIN AND BEHAVIOR (2019)
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
Jennifer L. Phillips et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy
Jennifer Dore et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2019)
Maintenance Ketamine Therapy for Treatment-Resistant Depression
Shaina Archer et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2018)
Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital
Samuel T. Wilkinson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2018)
A Circadian Genomic Signature Common to Ketamine and Sleep Deprivation in the Anterior Cingulate Cortex
Ricardo Orozco-Solis et al.
BIOLOGICAL PSYCHIATRY (2017)
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Jaskaran B. Singh et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Continuation phase intravenous ketamine in adults with treatment resistant depression
Jennifer L. Vande Voort et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
D. Jeffrey Newport et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
James W. Murrough et al.
BIOLOGICAL PSYCHIATRY (2013)
Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder
Mark J. Niciu et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Ketamine Influences CLOCK:BMAL1 Function Leading to Altered Circadian Gene Expression
Marina M. Bellet et al.
PLOS ONE (2011)
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Marije aan het Rot et al.
BIOLOGICAL PSYCHIATRY (2010)
Monitoring depression treatment outcomes with the patient health questionnaire-9
B Löwe et al.
MEDICAL CARE (2004)
The PHQ-9 - Validity of a brief depression severity measure
K Kroenke et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2001)
Share Paper
